Renalytix plc
Datakwaliteit: 100%
€ 1,40
▲
€ 0,02
(1,45%)
Marktkapitalisatie: 305,91 M
Prijs
€ 1,40
Marktkapitalisatie
305,91 M
Dagbereik
€ 1,35 — € 1,35
52-Weeksbereik
€ 1,31 — € 202,50
Volume
2.192
Openen € 1,35
50D / 200D Gem.
€ 2,69
48,00% below
50D / 200D Gem.
€ 78,13
98,21% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -24,44 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-32,74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin-1191,75%
Op. Margin-1054,93%
Veiligheid
Debt / Equity
N/A
Current Ratio0,24
Interest CoverageN/A
Waardering
PE (TTM)
-10,91
Onder sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Services sector mediaan (502 peers)
Sectorvergelijking
vs Services sector mediaan (502 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,9 | -1,2 |
| P/B | — | 1,4 |
| ROE % | — | -16,0 |
| Net Margin % | -1191,8 | -19,4 |
| Rev Growth 5Y % | — | 4,0 |
| D/E | — | 0,4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -32,74% | Revenue Growth (3Y) | -12,21% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,35 M | Net Income (TTM) | -28,03 M |
| ROE | N/A | ROA | -413,33% |
| Gross Margin | 12,71% | Operating Margin | -1054,93% |
| Net Margin | -1191,75% | Free Cash Flow (TTM) | -24,44 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,24 |
| Interest Coverage | N/A | Asset Turnover | 0,35 |
| Working Capital | -9,13 M | Tangible Book Value | -12,19 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10,91 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 130,07 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7,99% | ||
| Market Cap | 305,91 M | Enterprise Value | 305,00 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,24 | Revenue / Share | 0,01 |
| FCF / Share | -0,11 | OCF / Share | -0,11 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 87,20% |
| SBC-Adj. FCF | -25,99 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 2,29 M | 3,40 M | 2,97 M | 1,49 M | — |
| Net Income | -33,46 M | -45,61 M | -45,28 M | -35,34 M | -9,84 M |
| EPS (Diluted) | -0,31 | -0,55 | -0,67 | — | — |
| Gross Profit | 156.000,0 | 720.000,0 | 874.000,0 | 633.000,0 | — |
| Operating Income | -29,61 M | -42,22 M | -53,18 M | -31,92 M | -10,32 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 364.000,0 | 508.000,0 | 489.000,0 | 282.000,0 | 70.000,0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 4.000,0 | 2.000,0 | 25.000,0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 7,97 M | 30,63 M | 50,07 M | 78,58 M | 20,83 M |
| Total Liabilities | 15,83 M | 23,66 M | 19,46 M | 7,12 M | 4,97 M |
| Shareholders' Equity | -7,85 M | 6,97 M | 30,61 M | 71,46 M | 15,91 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 4,68 M | 24,68 M | 41,33 M | 65,13 M | 13,29 M |
| Current Assets | 6,12 M | 26,88 M | 44,75 M | 66,79 M | 14,84 M |
| Current Liabilities | 11,50 M | 16,14 M | 11,78 M | 7,06 M | 3,29 M |
{"event":"ticker_viewed","properties":{"ticker":"RNLXY","listing_kind":"stock","pathname":"/stocks/rnlxy","exchange":"OTC","country":"US"}}